Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Gains from Investment Securities: 2019-2025

Historic Gains from Investment Securities for AvePoint (AVPT) over the last 5 years, with Sep 2025 value amounting to $2.3 million.

  • AvePoint's Gains from Investment Securities rose 2605.88% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.0 million, marking a year-over-year increase of 312.41%. This contributed to the annual value of $23.3 million for FY2024, which is 14.39% down from last year.
  • Per AvePoint's latest filing, its Gains from Investment Securities stood at $2.3 million for Q3 2025, which was down 82.17% from $12.9 million recorded in Q2 2025.
  • AvePoint's 5-year Gains from Investment Securities high stood at $40.0 million for Q4 2021, and its period low was -$1.9 million during Q2 2023.
  • Its 3-year average for Gains from Investment Securities is $10.1 million, with a median of $2.3 million in 2025.
  • In the last 5 years, AvePoint's Gains from Investment Securities spiked by 28,471.43% in 2022 and then plummeted by 194.75% in 2023.
  • Quarterly analysis of 5 years shows AvePoint's Gains from Investment Securities stood at $40.0 million in 2021, then crashed by 80.89% to $7.6 million in 2022, then spiked by 63.94% to $12.5 million in 2023, then spiked by 176.81% to $34.7 million in 2024, then surged by 2,605.88% to $2.3 million in 2025.
  • Its Gains from Investment Securities was $2.3 million in Q3 2025, compared to $12.9 million in Q2 2025 and $23.1 million in Q1 2025.